BofA Securities raised its price target on Eli Lilly to $1,251 from $1,133 and kept a Buy rating, saying the drugmaker remains well place ...

Eli Lilly (LLY) stock extended gains on Tuesday and Wednesday after the pharmaceutical behemoth said it’s buying three ...

With a market capitalization of $1 trillion, Eli Lilly and Company (LLY) is a global pharmaceutical company focused on ...

While Eli Lilly has slightly lagged behind the SPX over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

At first glance, Eli Lilly's (NYSE: LLY) current share price of $903 feels like a psychological barrier. Most investors fixate on the absolute dollars and assume anything this expensive must be priced ...

Eli Lilly (LLY 1.87%) just delivered another fantastic quarter, showcasing its impressive growth prospects. The company has ...

Eli Lilly (NYSE:LLY | LLY Price Prediction) is growing like a software company. Q1 2026 revenue hit $19.80B, up 55.5% year ...

Shares of Eli Lilly and Company LLY have declined 5.2% in the past month despite the company reporting robust fourth-quarter 2025 results on Feb. 4. Industry pricing concerns, rising competitive ...

The company is riding an incredible tailwind.

Eli Lilly is a market darling at the moment because of its industry-leading GLP-1 drugs. The stock looks priced for perfection despite a well-known drug cycle. Eli Lilly (NYSE: LLY) wasn't the first ...